Skip to main content
logo
Beryl Drugs Limited (BOM:524606)
India flag India · Delayed Price · Currency is INR
21.72
-0.28 (-1.27%)
At close: Jul 28, 2026

Beryl Drugs Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
188.2188.2211.46267.3268.71146.04
Revenue Growth
-11.00%-11.00%-20.89%-0.53%84.00%3.62%
Gross Profit
90.5490.5499.24131.68120.2860.37
Operating Income
9.329.3213.7714.4414.1-5.35
Net Income
4.254.255.797.697.66-6.59
Earnings Per Share
0.840.841.141.521.51-1.30
EPS Growth
-26.32%-26.32%-24.78%0.36%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2.742.748.141.255.746.72
Total Debt
24.4124.414150.9445.4252.94
Net Cash (Debt)
-21.67-21.67-32.86-49.69-39.68-46.22
Net Cash Growth
------
Net Cash Per Share
-4.29-4.29-6.48-9.80-7.82-9.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
36.536.526.378.223.91-4.69
Capital Expenditures
-38.24-38.24-21.85-13.52-15.64-4.16
Free Cash Flow
-1.75-1.754.52-5.318.28-8.84
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
48.10%48.10%46.93%49.26%44.76%41.34%
Operating Margin
4.95%4.95%6.51%5.40%5.25%-3.66%
Pretax Margin
3.12%3.12%4.09%3.78%3.66%-6.51%
Profit Margin
2.26%2.26%2.74%2.88%2.85%-4.51%
FCF Margin
-0.93%-0.93%2.14%-1.99%3.08%-6.05%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
25.8623.0218.4519.358.05-
P/FCF Ratio
--23.65-7.45-
PS Ratio
0.590.520.510.560.230.36